Abstract
A clinical decision report appraising
Oelke M, Giuliano F, Mirone V, Xu L, Cox D, Viktrup L. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomized, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://doi.org/10.1016/j.eururo.2012.01.0131
for a vigorous 75-year-old man with benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) who discontinued dutasteride due to intolerable sexual side effects.
DOI
10.22237/crp/1770638400
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
IBRAHIM DM, AHMED A, REDDY S, PATEL MS, SUMBAL N, CHABAN A, FAYYAZ AI. Tadalafil monotherapy is a reasonable alternative for the treatment of lower urinary tract symptoms in patients with comorbid benign prostatic hyperplasia and erectile dysfunction. Clin Res Prac. Feb 24 2026;12(1):eP3606. https://doi.org/10.22237/crp/1770638400
Included in
Family Medicine Commons, Male Urogenital Diseases Commons, Medical Education Commons, Primary Care Commons, Translational Medical Research Commons, Urology Commons
